Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CAMPATH safely and effectively. See full prescribing information for CAMPATH. CAMPATH® (alemtuzumab) injection, for intravenous useInitial U.S. Approval: 2001
Medication labelWhy this: Advisory · dailymed-prescription
CAMPATH is indicated as a single agent for the treatment of B-cell chronic lymphocytic leukemia (B-CLL).
- generic_name
- alemtuzumab
- product_names
- ALEMTUZUMAB
- ndc
- 58468-0357, 58468-0357-1, 58468-0357-3
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en